Synopsys Inc (SNPS) investors sentiment increased to 1.06 in Q4 2017. It’s up 0.05, from 1.01 in 2017Q3. The ratio is more positive, as 204 active investment managers opened new or increased holdings, while 193 sold and reduced equity positions in Synopsys Inc. The active investment managers in our database reported: 130.26 million shares, down from 131.73 million shares in 2017Q3. Also, the number of active investment managers holding Synopsys Inc in top ten holdings decreased from 7 to 6 for a decrease of 1. Sold All: 24 Reduced: 169 Increased: 132 New Position: 72.
Rivulet Capital Llc increased Cinemark Holdings Inc (CNK) stake by 87.96% reported in 2017Q4 SEC filing. Rivulet Capital Llc acquired 1.34 million shares as Cinemark Holdings Inc (CNK)’s stock rose 5.40%. The Rivulet Capital Llc holds 2.86M shares with $99.56 million value, up from 1.52 million last quarter. Cinemark Holdings Inc now has $4.12B valuation. The stock decreased 2.95% or $1.07 during the last trading session, reaching $35.26. About 1.01 million shares traded. Cinemark Holdings, Inc. (NYSE:CNK) has declined 11.39% since May 20, 2017 and is downtrending. It has underperformed by 22.94% the S&P500.
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits (ICs). The company has market cap of $13.27 billion. It offers Galaxy Design platform that provides IC design solutions; Verification Continuum Platform, which offers virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA) prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It has a 292.62 P/E ratio. The firm also provides DesignWare intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating point components, and ARM AMBA interconnect fabric and peripherals.
Ratings analysis reveals 75% of Synopsys’s analysts are positive. Out of 4 Wall Street analysts rating Synopsys, 3 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $60.0 while the high is $68.0. The stock’s average target of $63 is -29.41% below today’s ($89.25) share price. SNPS was included in 4 notes of analysts from August 18, 2016. The stock has “Buy” rating by DA Davidson on Thursday, August 18. Credit Suisse initiated Synopsys, Inc. (NASDAQ:SNPS) on Wednesday, October 19 with “Outperform” rating. The firm has “Hold” rating by Benchmark given on Thursday, August 18. Needham maintained Synopsys, Inc. (NASDAQ:SNPS) rating on Thursday, August 18. Needham has “Buy” rating and $60.0 target.
More recent Synopsys, Inc. (NASDAQ:SNPS) news were published by: Prnewswire.com which released: “Synopsys IC Validator Certified by GLOBALFOUNDRIES for Signoff Physical Verification” on May 14, 2018. Also Prnewswire.com published the news titled: “Synopsys Announces Earnings Release Date for Second Quarter Fiscal Year 2018” on May 09, 2018. Prnewswire.com‘s news article titled: “Synopsys Report Finds Majority of Software Plagued by Known Vulnerabilities and License Conflicts as Open Source …” with publication date: May 15, 2018 was also an interesting one.
Analysts await Synopsys, Inc. (NASDAQ:SNPS) to report earnings on May, 23 after the close. They expect $0.73 EPS, up 2.82% or $0.02 from last year’s $0.71 per share. SNPS’s profit will be $108.57 million for 30.57 P/E if the $0.73 EPS becomes a reality. After $0.74 actual EPS reported by Synopsys, Inc. for the previous quarter, Wall Street now forecasts -1.35% negative EPS growth.
The stock increased 0.39% or $0.35 during the last trading session, reaching $89.25. About 857,240 shares traded. Synopsys, Inc. (SNPS) has risen 16.16% since May 20, 2017 and is uptrending. It has outperformed by 4.61% the S&P500.
Robertson Opportunity Capital Llc holds 4.5% of its portfolio in Synopsys, Inc. for 90,000 shares. Bernzott Capital Advisors owns 322,071 shares or 3.63% of their US portfolio. Moreover, Westport Asset Management Inc has 3.13% invested in the company for 51,500 shares. The Massachusetts-based Contravisory Investment Management Inc. has invested 2.22% in the stock. Ami Asset Management Corp, a California-based fund reported 262,818 shares.
Since January 1, 0001, it had 0 buys, and 7 sales for $5.22 million activity.
More news for Cinemark Holdings, Inc. (NYSE:CNK) were recently published by: Fool.ca, which released: “Is Cineplex Odeon a Value Trap?” on May 20, 2018. Globenewswire.com‘s article titled: “Investor Expectations to Drive Momentum within Plains Group Holdings, EnteroMedics, Vanda Pharmaceuticals …” and published on May 10, 2018 is yet another important article.
Since December 12, 2017, it had 0 insider purchases, and 2 sales for $11.18 million activity. Shares for $10.92M were sold by MITCHELL LEE ROY. Fernandes Valmir sold $261,540 worth of Cinemark Holdings, Inc. (NYSE:CNK) on Wednesday, February 28.
Among 22 analysts covering Cinemark Holdings (NYSE:CNK), 15 have Buy rating, 1 Sell and 6 Hold. Therefore 68% are positive. Cinemark Holdings had 76 analyst reports since July 23, 2015 according to SRatingsIntel. B. Riley & Co maintained Cinemark Holdings, Inc. (NYSE:CNK) on Monday, July 31 with “Buy” rating. RBC Capital Markets downgraded Cinemark Holdings, Inc. (NYSE:CNK) rating on Monday, February 27. RBC Capital Markets has “Sector Perform” rating and $45 target. The firm has “Buy” rating given on Thursday, February 18 by Topeka Capital Markets. The rating was downgraded by Macquarie Research on Tuesday, September 8 to “Neutral”. The firm earned “Buy” rating on Friday, August 11 by Piper Jaffray. FBR Capital maintained it with “Buy” rating and $42.5 target in Friday, February 23 report. The rating was maintained by Wunderlich on Tuesday, October 4 with “Buy”. The rating was upgraded by BB&T Capital on Friday, August 7 to “Hold”. The firm has “Buy” rating by FBR Capital given on Monday, November 6. FBR Capital maintained the shares of CNK in report on Friday, February 24 with “Outperform” rating.